Evolution of Canadian Intellectual Property Legislation Affecting Innovative Drug Products

Publication | January 2012

The Norton Rose Canada LLP Guide to the "Evolution of Canadian Intellectual Property Legislation Affecting Innovative Drug Products" provides a brief historical survey of the legislative protection extended to innovative drug products in Canada, including a consideration of Canada's international treaty obligations respecting IP rights.

Download Evolution of Canadian Intellectual Property Legislation Affecting Innovative Drug Products (pdf 431kb)


Contacts

Judith Robinson

Judith Robinson

Montréal
Brian R. Daley

Brian R. Daley

Montréal